Clinical Trials Logo

Clinical Trial Summary

Protocol CP-4-004-EXT is designed as a long-term, open-label extension using single patient use, multi-dose, disposable pre-filled pen.


Clinical Trial Description

n/a


Study Design


Related Conditions & MeSH terms


NCT number NCT02500316
Study type Interventional
Source OPKO Health, Inc.
Contact
Status Completed
Phase Phase 2
Start date February 2013
Completion date November 2023

See also
  Status Clinical Trial Phase
Active, not recruiting NCT00271518 - Treatment of Children With Insufficient Secretion of Growth Hormone Phase 3
Terminated NCT01237340 - Saizen® Solution for Injection Adult Growth Hormone Deficiency (GHD) Immunogenicity Study Phase 3
Completed NCT01947907 - Safety, PK/PD and Efficacy of ACP-001 Weekly Versus Daily hGH in Children With Growth Hormone Deficiency (GHD) Phase 2